Cargando…
The use of neutrophil elastase inhibitor in the treatment of acute lung injury after pneumonectomy
BACKGROUND: The prognosis of acute lung injury (ALI) after pneumonectomy is poor, with reported mortality rates of 30-100%. Neutrophil elastase inhibitor (NEI) is known to prevent lung injury caused by neutrophil elastase and improve lung function in ALI. We evaluated the effect of NEI on ALI after...
Autores principales: | Lee, Sang Kwon, Son, Bong Soo, Hwang, Jung Joo, Kim, Kil Dong, Kim, Do Hyung |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3680002/ https://www.ncbi.nlm.nih.gov/pubmed/23566653 http://dx.doi.org/10.1186/1749-8090-8-69 |
Ejemplares similares
-
The neutrophil elastase inhibitor, sivelestat, attenuates acute lung injury in patients with cardiopulmonary bypass
por: Pan, Tuo, et al.
Publicado: (2023) -
Usefulness of a selective neutrophil elastase inhibitor, sivelestat, in acute lung injury patients with sepsis
por: Miyoshi, Seigo, et al.
Publicado: (2013) -
Corrigendum: The neutrophil elastase inhibitor, Sivelestat, attenuates acute lung injury in patients with cardiopulmonary bypass
por: Pan, Tuo, et al.
Publicado: (2023) -
Flavonoids as inhibitors of human neutrophil elastase
por: Jakimiuk, Katarzyna, et al.
Publicado: (2021) -
Susceptibility of lung epithelium to neutrophil elastase: protection by native inhibitors
por: Bingle, L., et al.
Publicado: (1997)